Filtros : "PROTEÍNAS" "Financiado pelo FEDER" Removido: "Alemão" Limpar

Filtros



Refine with date range


  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: PROTEÍNAS, ENZIMAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, João Henrique Picado Madalena et al. Protein PEGylation for the design of biobetters: from reaction to purification processes. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-17 art. e01009, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001009. Acesso em: 23 ago. 2024.
    • APA

      Santos, J. H. P. M., Obreque, K. M. T., Meneguetti, G. P., Amaro, B. P., & Rangel-Yagui, C. de O. (2018). Protein PEGylation for the design of biobetters: from reaction to purification processes. Brazilian Journal of Pharmaceutical Sciences, 54, 1-17 art. e01009. doi:10.1590/s2175-97902018000001009
    • NLM

      Santos JHPM, Obreque KMT, Meneguetti GP, Amaro BP, Rangel-Yagui C de O. Protein PEGylation for the design of biobetters: from reaction to purification processes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-17 art. e01009.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1590/s2175-97902018000001009
    • Vancouver

      Santos JHPM, Obreque KMT, Meneguetti GP, Amaro BP, Rangel-Yagui C de O. Protein PEGylation for the design of biobetters: from reaction to purification processes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-17 art. e01009.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1590/s2175-97902018000001009
  • Source: European Journal of Pharmaceutical Sciences. Unidade: EP

    Subjects: LIPÍDEOS, NANOPARTÍCULAS, PROTEÍNAS, NANOTECNOLOGIA, GENES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SEVERINO, Patrícia et al. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, v. 66, p. 78-82, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2014.09.021. Acesso em: 23 ago. 2024.
    • APA

      Severino, P., Szymanski, M., Favaro, M. T. de P., Azzoni, A. R., Chaud, M. V., Santana, M. H. A., et al. (2015). Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, 66, 78-82. doi:10.1016/j.ejps.2014.09.021
    • NLM

      Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021
    • Vancouver

      Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024